1. Home
  2. AYI vs RGEN Comparison

AYI vs RGEN Comparison

Compare AYI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acuity Brands Inc.

AYI

Acuity Brands Inc.

N/A

Current Price

$310.99

Market Cap

9.6B

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$164.21

Market Cap

11.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AYI
RGEN
Founded
2001
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
11.0B
IPO Year
2001
1995

Fundamental Metrics

Financial Performance
Metric
AYI
RGEN
Price
$310.99
$164.21
Analyst Decision
Buy
Buy
Analyst Count
7
20
Target Price
★ $370.17
$203.21
AVG Volume (30 Days)
224.4K
★ 1.1M
Earning Date
01-07-2027
10-27-2026
Dividend Yield
★ 0.25%
N/A
EPS Growth
36.07
★ 286.96
EPS
★ 17.05
N/A
Revenue
★ $3,461,000,000.00
$141,236,000.00
Revenue This Year
$4.09
$14.98
Revenue Next Year
$5.15
$26.02
P/E Ratio
$18.79
★ N/A
Revenue Growth
4.05
★ 35.10
52 Week Low
$257.04
$100.99
52 Week High
$380.17
$198.87

Technical Indicators

Market Signals
Indicator
AYI
RGEN
Relative Strength Index (RSI) 40.54 42.60
Support Level $294.06 $161.15
Resistance Level $316.95 $188.59
Average True Range (ATR) 9.88 7.51
MACD -2.15 -0.81
Stochastic Oscillator 4.76 12.07

Price Performance

Historical Comparison
AYI
RGEN

About AYI Acuity Brands Inc.

Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. It designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: